Moderna's revenue for the
three
months ended in Jun. 2023 was $316 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $10,523 Mil.
Moderna's Revenue per Share for the
three
months ended in Jun. 2023 was $0.83.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $25.83.
Warning Sign:
Moderna Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Moderna was -50.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 578.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 166.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 7 years, Moderna's highest 3-Year average Revenue per Share Growth Rate was 578.90% per year. The lowest was -18.70% per year. And the median was 108.00% per year.
Moderna Revenue Historical Data
The historical data trend for Moderna's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Moderna Annual Data
Trend
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Revenue
122.51
48.00
274.00
17,736.00
18,875.00
Moderna Quarterly Data
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Revenue
4,566.00
3,220.00
5,149.00
1,838.00
316.00
Competitive Comparison
For the Biotechnology subindustry, Moderna's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moderna Revenue Distribution
For the Biotechnology industry and Healthcare sector, Moderna's Revenue distribution charts can be found below:
* The bar in red indicates where Moderna's Revenue falls in comparison to its industry or sector. The grey bar indicates the Revenue's extreme value range as defined by GuruFocus.
Moderna Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10,523 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moderna (NAS:MRNA) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Moderna Revenue Related Terms
Thank you for viewing the detailed overview of Moderna's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0.24(0.24%) Volume: 2,258,282 11:09PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
MRNA has been successfully added to your 
